INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 94 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 34.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,872,000 | -17.5% | 1,386,687 | -4.7% | 0.00% | – |
| Q3 2016 | $2,270,000 | +25.6% | 1,455,317 | +7.1% | 0.00% | – |
| Q2 2016 | $1,807,000 | -72.1% | 1,358,322 | +10.7% | 0.00% | -100.0% |
| Q1 2016 | $6,467,000 | -40.1% | 1,227,205 | -10.8% | 0.00% | -50.0% |
| Q4 2015 | $10,799,000 | -7.2% | 1,375,727 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $11,639,000 | -25.2% | 1,377,356 | -3.1% | 0.00% | -33.3% |
| Q2 2015 | $15,562,000 | -22.5% | 1,421,160 | -1.0% | 0.00% | 0.0% |
| Q1 2015 | $20,070,000 | -15.8% | 1,435,644 | +1.8% | 0.00% | -25.0% |
| Q4 2014 | $23,824,000 | +34.7% | 1,410,551 | +7.0% | 0.00% | +33.3% |
| Q3 2014 | $17,686,000 | +1.0% | 1,317,849 | -4.1% | 0.00% | 0.0% |
| Q2 2014 | $17,514,000 | +8.2% | 1,374,751 | +1.0% | 0.00% | 0.0% |
| Q1 2014 | $16,187,000 | -9.9% | 1,361,396 | +4.7% | 0.00% | 0.0% |
| Q4 2013 | $17,962,000 | -19.3% | 1,300,626 | +1.9% | 0.00% | -25.0% |
| Q3 2013 | $22,249,000 | +3.1% | 1,276,493 | -4.3% | 0.00% | 0.0% |
| Q2 2013 | $21,587,000 | – | 1,333,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |